Hälsa & medicin
4.1
Blood cancer patients face heightened COVID-19 risk, study warns
A European registry analysis found that patients with Philadelphia-negative myeloproliferative neoplasms—a group of blood cancers—experienced worse outcomes from SARS-CoV-2 infection than the general population. The finding has implications for how hospitals manage immunocompromised cancer patients and inform clinical treatment decisions during future pandemic waves.
Originaltitel: Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry